Hemoadsorption for Severe Ischemic Stroke

NANot yet recruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 30, 2026

Conditions
Ischemic StrokeHemoadsorption
Interventions
PROCEDURE

Hemoadsorption

Patients in intervention group will receive standard treatment plus hemoadsorption therapy administered once on days 1, 3, and 5 following enrollment.

All Listed Sponsors
collaborator

The Second People's Hospital of Wuhu

UNKNOWN

collaborator

Lu'an People's Hospital of Anhui Province

UNKNOWN

collaborator

Anqing People's Hospital of Anhui Medical University

UNKNOWN

collaborator

TAIHE country people's hospital

UNKNOWN

collaborator

Beijing Tiantan Hospital

OTHER

collaborator

Gansu Provincial Central Hospital

UNKNOWN

collaborator

Baotou Central Hospital

OTHER

collaborator

Sichuan Provincial People's Hospital

OTHER

collaborator

The NO.1 People's Hospital of Shizuishan

UNKNOWN

lead

First Affiliated Hospital of Wannan Medical College

OTHER

NCT07127484 - Hemoadsorption for Severe Ischemic Stroke | Biotech Hunter | Biotech Hunter